Add To Watchlist
Share URL
About The Company
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.
Read More
Overview
Value
0
Growth
20
Health
56
Management
0
Analyst Opinion
71
Total
44
All Scores Out Of 100
Best Features
- Has a low level of debt
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative 0
- Disliked by Twitter users
- Poor earnings and cashflow growth 0
Latest News

Healthcare company Accolade lays off workers and closes offices
GeekWire | 01:32 Tue 7 Mar 2023
Read More →

Why Shares of Accolade Soared This Week
The Motley Fool | 17:39 Fri 13 Jan 2023
Read More →

Accolade, Inc. (ACCD) Q3 2023 Earnings Call Transcript
Seeking Alpha | 02:58 Tue 10 Jan 2023
Read More →

Accolade (ACCD) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research | 23:48 Mon 9 Jan 2023
Read More →
Market Peers
ACCD
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Buy
Share Buybacks
N/A
Dividend Yeild (TTM)
N/A
Valuation
Value Score
0
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 13.4 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-7.98%
PE/Earnings Growth
N/A
Price/Book
2.00x
Growth
Growth Score
20
- ✔ Revenue growth has improved this yeara
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
N/A
Earnings Growth
N/A
Cashflow Growth
N/A
Health
Health Score
56
Altman Z Score
N/A
Piostroski Score
5.00
Debt/Equity
0.37x
Current Assets/Liabilities
3.66x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.78x
Management
Management Score
0
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
14.04%
5 Year Price Volitility
38.74%
Return On Assets
-10.93%
Return On Capital Employed
-2.91%
Return On Equity
-16.41%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
71
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Accolade, Inc.
Currency
USD
Beta
1.358294
Vol Avg
667377
Ceo
Mr. J. Michael Cline
Cik
0001481646
Cusip
00437E102
Exchange
NASDAQ Global Select
Full Time Employees
2350
Industry
Health Information Services
Sector
Healthcare
Ipo Date
2020-07-02
Address
660 West Germantown Pike
City
Plymouth Meeting
State
PA
Country
US
Zip
19462
Phone
206 926 8100
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
30
Twitter Sentiment
N/A
Stocktwits Sentiment
59.00